Table 1

Demographic information and mean visual acuity at baseline and 6, 12, 18, 24 and 36 months (the number of eyes with a measurement at each point is shown in parentheses). Data on treatment burden and the numbers and percentages of eyes switching treatment are also shown

Anti-VEGFMacular laserDexamethasone
Mean age at baseline72.072.571.9
Gender (% male)47.448.645.9
Baseline CF (%)57 (1.3)14 (2.2)14 (2.1)
Baseline HM (%)23 (0.6)2 (0.3)3 (0.4)
Mean VA in ETDRS letters (n)
At baseline57.1 (3859)62.3 (620)53.1 (659)
At 6 months65.9 (1598)60.9 (110)59.7 (188)
At 12 months66.7 (1042)63.2 (53)57.6 (95)
At 18 months66.6 (713)60.8 (48)56.1 (71)
At 24 months67.2 (485)56.4 (30)59.3 (45)
At 36 months68 (203)50.1 (23)62.9 (20)
  • anti-VEGF, anti-vascular endothelial growth factor; CF, counting fingers; HM, hand movement; VA, visual acuity.